Your browser doesn't support javascript.
loading
The clinical spectrum of reversible cerebral vasoconstriction syndrome: The Italian Project on Stroke at Young Age (IPSYS).
Caria, Filomena; Zedde, Marialuisa; Gamba, Massimo; Bersano, Anna; Rasura, Maurizia; Adami, Alessandro; Piantadosi, Carlo; Quartuccio, Luca; Azzini, Cristiano; Melis, Maurizio; Luisa Delodovici, Maria; Dallocchio, Carlo; Gandolfo, Carlo; Cerrato, Paolo; Motto, Cristina; Melis, Fabio; Chiti, Alberto; Gentile, Mauro; Bignamini, Valeria; Morotti, Andrea; Maria Lotti, Enrico; Toriello, Antonella; Costa, Paolo; Silvestrelli, Giorgio; Zini, Andrea; De Giuli, Valeria; Poli, Loris; Paciaroni, Maurizio; Lodigiani, Corrado; Marcheselli, Simona; Sanguigni, Sandro; Del Sette, Massimo; Monaco, Serena; Lochner, Piergiorgio; Zanferrari, Carla; Anticoli, Sabrina; Padovani, Alessandro; Pezzini, Alessandro.
Afiliação
  • Caria F; 1 Dipartimento di Scienze Cliniche e Sperimentali, Clinica Neurologica, Università degli Studi di Brescia, Brescia, Italy.
  • Zedde M; 2 SC Neurologia, Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Reggio Emilia, Italy.
  • Gamba M; 3 Stroke Unit, Neurologia Vascolare, Spedali Civili di Brescia, Brescia, Italy.
  • Bersano A; 4 UO Malattie Cerebrovascolari, Fondazione IRCCS Istituto Neurologico "Carlo Besta", Milan, Italy.
  • Rasura M; 5 Stroke Unit, Azienda Ospedaliera Sant'Andrea, Università "La Sapienza", Rome, Italy.
  • Adami A; 6 Stroke Center, Dipartimento di Neurologia, Ospedale Sacro Cuore Negrar, Verona, Italy.
  • Piantadosi C; 7 UOC Neurologia, Azienda Ospedaliera "San Giovanni-Addolorata", Rome, Italy.
  • Quartuccio L; 8 Clinica di Reumatologia, Dipartimento di Area Medica, Azienda Ospedaliero-Universitaria "Santa Maria della Misericordia", Udine, Italy.
  • Azzini C; 9 UO di Neurologia, Dipartimento di Neuroscienze e Riabilitazione, Azienda Ospedaliero-Universitaria di Ferrara, Ferrara, Italy.
  • Melis M; 10 SC Neurologia and Stroke Unit, Dipartimento Neuroscienze e Riabilitazione, Azienda Ospedaliera "G. Brotzu", Cagliari, Italy.
  • Luisa Delodovici M; 11 Unità di Neurologia, Ospedale di Circolo, Università dell'Insubria, Varese, Italy.
  • Dallocchio C; 12 Dipartimento di Area Medica, UOC Neurologia, ASST Pavia, Voghera, Italy.
  • Gandolfo C; 13 Dipartimento di Neuroscienze, Riabilitazione, Oftalmologia, Genetica e Scienze Materno-Infantili, Università di Genova, Genoa, Italy.
  • Cerrato P; 14 Dipartimento di Neuroscienze, Stroke Unit, Università di Torino, Torino, Italy.
  • Motto C; 15 Stroke Unit, Dipartmento di Scienze Neurologiche, Azienda Ospedaliera "Niguarda Ca' Granda", Milan, Italy.
  • Melis F; 16 SS NeuroVascolare Ospedale Maria Vittoria, ASL Città di Torino, Torino, Italy.
  • Chiti A; 17 UO Neurologia, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy.
  • Gentile M; 18 UO Neurologia - Stroke Unit, Ospedale "Santa Maria della Misericordia", Rovigo, Italy.
  • Bignamini V; 19 Stroke Unit, U.O Neurologia, Ospedale "S. Chiara", Trento, Italy.
  • Morotti A; 20 UC Malattie Cerebrovascolari, IRCCS Fondazione Mondino, Pavia, Italy.
  • Maria Lotti E; 21 Unità Operativa Complessa Neurologia, AUSL Romagna, Ravenna, Italy.
  • Toriello A; 22 Unità Operativa Complessa Neurologia, Azienda Ospedaliera Universitaria "San Giovanni di Dio e Ruggi d'Aragona", Salerno, Italy.
  • Costa P; 23 UO Neurologia, Istituto Ospedaliero Poliambulanza, Brescia, Italy.
  • Silvestrelli G; 24 Stroke Unit, Dipartimento di Neuroscienze, Ospedale Carlo Poma, Mantova, Italy.
  • Zini A; 25 Stroke Unit, Clinica Neurologica, Nuovo Ospedale Civile "S. Agostino Estense", AUSL Modena, Italy.
  • De Giuli V; 1 Dipartimento di Scienze Cliniche e Sperimentali, Clinica Neurologica, Università degli Studi di Brescia, Brescia, Italy.
  • Poli L; 1 Dipartimento di Scienze Cliniche e Sperimentali, Clinica Neurologica, Università degli Studi di Brescia, Brescia, Italy.
  • Paciaroni M; 26 Stroke Unit and Divisione di Medicina Cardiovascolare, Università di Perugia, Italy.
  • Lodigiani C; 27 Centro Trombosi e Malattie Emorragiche, Humanitas Clinical and Research Center, IRCCS, Rozzano-Milano, Italy.
  • Marcheselli S; 28 Neurologia d'Urgenza and Stroke Unit, Humanitas Clinical and Research Center, IRCCS, Rozzano-Milano, Italy.
  • Sanguigni S; 29 Dipartmento di Neurologia, Ospedale "Madonna del Soccorso", San Benedetto del Tronto, Italy.
  • Del Sette M; 30 Unità di Neurologia, E.O. Ospedali Galliera, Genova, Italy.
  • Monaco S; 31 Stroke Unit, Ospedale Civico, Palermo, Italy.
  • Lochner P; 32 Dipartimento di Neurologia, Saarland University Medical Center, Homburg, Germany.
  • Zanferrari C; 33 UOC Neurologia, ASST Melegnano-Martesana, Vizzolo Predabissi, Italy.
  • Anticoli S; 34 Stroke Unit, Dipartimento di Emergenza-Urgenza, Ospedale "S. Camillo-Forlanini", Rome, Italy.
  • Padovani A; 1 Dipartimento di Scienze Cliniche e Sperimentali, Clinica Neurologica, Università degli Studi di Brescia, Brescia, Italy.
  • Pezzini A; 1 Dipartimento di Scienze Cliniche e Sperimentali, Clinica Neurologica, Università degli Studi di Brescia, Brescia, Italy.
Cephalalgia ; 39(10): 1267-1276, 2019 Sep.
Article em En | MEDLINE | ID: mdl-31060368
INTRODUCTION: To describe clinical, neuroimaging, and laboratory features of a large cohort of Italian patients with reversible cerebral vasoconstriction syndrome. METHODS: In the setting of the multicenter Italian Project on Stroke at Young Age (IPSYS), we retrospectively enrolled patients with a diagnosis of definite reversible cerebral vasoconstriction syndrome according to the International Classification of Headache Disorders (ICHD)-3 beta criteria (6.7.3 Headache attributed to reversible cerebral vasoconstriction syndrome, imaging-proven). Clinical manifestations, neuroimaging, treatment, and clinical outcomes were evaluated in all patients. Characteristics of reversible cerebral vasoconstriction syndrome without typical causes ("idiopathic reversible cerebral vasoconstriction syndrome") were compared with those of reversible cerebral vasoconstriction syndrome related to putative causative factors ("secondary reversible cerebral vasoconstriction syndrome"). RESULTS: A total of 102 patients (mean age, 47.2 ± 13.9 years; females, 85 [83.3%]) qualified for the analysis. Thunderclap headache at presentation was reported in 69 (67.6%) patients, and it typically recurred in 42 (60.9%). Compared to reversible cerebral vasoconstriction syndrome cases related to putative etiologic conditions (n = 21 [20.6%]), patients with idiopathic reversible cerebral vasoconstriction syndrome (n = 81 [79.4%]) were significantly older (49.2 ± 13.9 vs. 39.5 ± 11.4 years), had more frequently typical thunderclap headache (77.8% vs. 28.6%) and less frequently neurological complications (epileptic seizures, 11.1% vs. 38.1%; cerebral infarction, 6.1% vs. 33.3%), as well as concomitant reversible brain edema (25.9% vs. 47.6%). CONCLUSIONS: Clinical manifestations and putative etiologies of reversible cerebral vasoconstriction syndrome in our series are slightly different from those observed in previous cohorts. This variability might be partly related to the coexistence of precipitating conditions with a putative etiologic role on disease occurrence.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vasoespasmo Intracraniano Tipo de estudo: Etiology_studies / Observational_studies Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Cephalalgia Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vasoespasmo Intracraniano Tipo de estudo: Etiology_studies / Observational_studies Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Cephalalgia Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Itália